In the latter study, the induction of cuproptosis and ferroptosis in MDS cells by ES-Cu/IKE was enhanced by modulating the xCT-GSH-GPX4 axis, providing new strategies for MDS treatment. Here, SLC7A11 is linked to myelodysplastic syndrome.